Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Chu, Maoping  [Clear All Filters]
Journal Article
Qian R, Wang L, Chen H, Ding Y, Wang D, Chen C, Chu M, Shan X, Guo X. Establishment of a human induced pluripotent stem cell line (WMUi031-A) from a Lowe syndrome patient carrying a OCRL gene mutation (c.2626dupA). Stem Cell Res. 2021;53:102294.
Guo X, Wang D, Shan X, Yang L, Ding Y, Chen H, Rong X, Chu M, Lin J, Chen C. Establishment of an induced pluripotent stem cell line from a Antley-Bixler Syndrome (ABS) patient with the homozygote mutation p.R457H (c.1370G>A) in POR gene. Stem Cell Res. 2021;52:102261.
Guo X, Qian R, Yang L, Chen H, Ding Y, Shan X, Chen C, Ni W, Lin J, Chu M. Establishment of an induced pluripotent stem cell line from a Noonan syndrome patient with the heterozygote mutation p.S257L (c.770C > T) in RAF1 gene. Stem Cell Res. 2021;53:102281.
Chen H, Ding Y, Zhou W, Li J, Qian W, Zhang Z, Li C, Tong H, Rong X, Chu M, et al. Establishment of an induced pluripotent stem cell line (WMUi016-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p.R718* (c.2152C > T) in the CLCN5 gene. Stem Cell Res. 2021;51:102209.
Guo X, Qian R, Shan X, Yang L, Chen H, Ding Y, Chen C, Chu M, Lin J, Wang D. Generation of a human induced pluripotent stem cell line (WMUi021-A) from a Gitelman syndrome patient carrying a SLC12A3 gene mutation (c.179C > T). Stem Cell Res. 2021;53:102280.
Ji W, Wang D, Chen C, Chen H, Ding Y, Li C, Rong X, Shan X, Chu M, Shen X, et al. Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene. Stem Cell Res. 2021;52:102228.
Guo X, Ji W, Niu C, Ding Y, Chen Z, Chen C, Tong H, Han Z, Chu M. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient. Stem Cell Res. 2020;49:102085.
Guo X, Zhang X, Wang L, He L, Ding Y, Chen H, Wang D, Rong X, Shen X, Lin J, et al. Generation of an urine-derived induced pluripotent stem cell line WMUi017-A from a X-linked Renpenning syndrome (X-RSY) patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G). Stem Cell Res. 2021;51:102159.
Guo X, Wang L, Chen K, Song S, Wang X, Gu X, Niu C, Chu M. Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation. Stem Cell Res. 2020;47:101886.
Yu J, Ming H, Li HYou, Yu B, Chu M, Zhu H, Zhu X. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling. Toxicol Appl Pharmacol. 2019:114732.